{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:11025495",
      "entity_text" : "cholesterol",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0445" ],
      "Organ" : [ "uberon:UBERON:0035552" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Evaluation of the effects of 24 weeks of tofacitinib treatment showed that increases in HDL cholesterol levels and decreases in the total cholesterol to HDL cholesterol ratio were associated with a diminished risk for future MACE, whereas increases in total cholesterol and LDL cholesterol levels lacked this protective effect [XREF_BIBR, XREF_BIBR].",
  "reading_complete" : "2020-07-28T16:07:59Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T15:56:14Z",
  "trigger" : "levels",
  "evidence" : [ "cholesterol levels" ],
  "pmc_id" : "7021876",
  "score" : 0
}